Feng-Ju Duan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Feng-Ju Duan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Chao Zhao
Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi’an City, China
1 shared publication - Chuan Li
Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi’an City, China
1 shared publication - Qi Yan
Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi’an City, China
1 shared publication - Wei Zhang
Department of Neurology, Tangdu Hospital, Fourth Military Medical University, China
1 shared publication - Ying Du
Department of Neurology, Tangdu Hospital, Fourth Military Medical University, China
1 shared publication - Zhuo Zhang
Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi’an City, China
1 shared publication
Latest Publications
- Open Access
- 11 January 2021
- Published by Springer Nature in BMC Neurology
- Vol. 21 (1) , 1-9
Mild cognitive impairment in novel SPG11 mutation-related sporadic hereditary spastic paraplegia with thin corpus callosum: case series
Background: SPG11 mutation-related autosomal recessive hereditary spastic paraplegia with thin corpus callosum (HSP-TCC) is the most common cause in complicated forms of HSP, usually presenting comprehensive mental retardation on early-onset stage preceding spastic paraplegias in childhood. However, there are many instances of sporadic late-onset HSP-TCC cases with a negative family history, and potential mild cognitive deficits in multiple domains may be easily neglected and inaccurately described. Methods: In this study, we performed next generation sequencing in four sporadic late-onset patients with HSP-TCC, and combined Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) to evaluate cognition of the patients. Results: By evolutionary conservation and structural modeling analysis, we have revealed 4 novel pathogenic SPG11 mutations, and firstly confirmed mild cognitive impairment (MCI) with normal MMSE scores (≥27) and decreased MoCA scores (< 26) in these SPG11 mutation-related HSP-TCC patients, predominantly presenting impairment of executive function, delayed recall, abstraction and language. Conclusions: The results expand the mutational spectrum of SPG11-associated HSP-TCC from sporadic cases, and confirm MCI with combination of decreased MoCA and normal MMSE assessment, suggesting that clinicians should consider doing a MoCA to detect MCI in patients with HSP, particularly those with HSP-TCC.
- 11 January 2021
- Published by Springer Nature in BMC Neurology
- Vol. 21 (1) , 1-9
Open AccessMild cognitive impairment in novel SPG11 mutation-related sporadic hereditary spastic paraplegia with thin corpus callosum: case series
Background: SPG11 mutation-related autosomal recessive hereditary spastic paraplegia with thin corpus callosum (HSP-TCC) is the most common cause in complicated forms of HSP, usually presenting comprehensive mental retardation on early-onset stage preceding spastic paraplegias in childhood. However, there are many instances of sporadic late-onset HSP-TCC cases with a negative family history, and potential mild cognitive deficits in multiple domains may be easily neglected and inaccurately described. Methods: In this study, we performed next generation sequencing in four sporadic late-onset patients with HSP-TCC, and combined Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) to evaluate cognition of the patients. Results: By evolutionary conservation and structural modeling analysis, we have revealed 4 novel pathogenic SPG11 mutations, and firstly confirmed mild cognitive impairment (MCI) with normal MMSE scores (≥27) and decreased MoCA scores (< 26) in these SPG11 mutation-related HSP-TCC patients, predominantly presenting impairment of executive function, delayed recall, abstraction and language. Conclusions: The results expand the mutational spectrum of SPG11-associated HSP-TCC from sporadic cases, and confirm MCI with combination of decreased MoCA and normal MMSE assessment, suggesting that clinicians should consider doing a MoCA to detect MCI in patients with HSP, particularly those with HSP-TCC.